Xenon Pharmaceuticals
XENE
$43.50
Share price
1.16%
Change (1 day)
8.26%
Change (1 year)
Categories
Xenon Pharmaceuticals (XENE) - Net assets
Net assets on the balance sheet as of December 2023 : $0.92 B
According to Xenon Pharmaceuticals's latest financial reports the company has $0.92 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Xenon Pharmaceuticals - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.92 B | 28.61% |
| 2022-12-31 | $0.72 B | 31.17% |
| 2021-12-31 | $0.55 B | 220.99% |
| 2020-12-31 | $0.17 B | 86.3% |
| 2019-12-31 | $91.97 M | -10.96% |
| 2018-12-31 | $0.10 B | 187.46% |
| 2017-12-31 | $35.93 M | -43.77% |
| 2016-12-31 | $63.9 M | 4.7% |
| 2015-12-31 | $61.03 M | -16.14% |
| 2014-12-31 | $72.77 M | 201.79% |
| 2013-12-31 | $24.11 M | 91.05% |
| 2012-12-31 | $12.62 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Coherus BioSciences
CHRS | -$0.2 B | -120.84% | 🇺🇸 USA |
 Atara Biotherapeutics ATRA | -$99.24 M | -110.69% | 🇺🇸 USA |